Compile Data Set for Download or QSAR
maximum 50k data
Found 13 of ic50 for UniProtKB: P29597
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127657(US10251889, Example 30 | US10758542, Example 30 | ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127679(US10251889, Example 52 | US10758542, Example 52 | ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127767(US10251889, Example 140 | US10758542, Example 140 ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127720(US10251889, Example 93 | US10758542, Example 93 | ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127733(US10251889, Example 106 | US10758542, Example 106 ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127741(US10251889, Example 114 | US10758542, Example 114 ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127821(US10251889, Example 195 | US10758542, Example 194 ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127718(US10251889, Example 91 | US10758542, Example 91 | ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127750(US10251889, Example 123 | US10758542, Example 123 ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127751(US10251889, Example 124 | US10758542, Example 124 ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127817(US10758542, Example 190 | US8791123, 190 | US97824...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127725(US10251889, Example 98 | US10758542, Example 98 | ...)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNon-receptor tyrosine-protein kinase TYK2 [886-1187](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM127808(US8791123, 181 | US9782415, Example 181)
Affinity DataIC50: >1.00E+3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...More data for this Ligand-Target Pair
In DepthDetails US Patent